LAURA ARSENIS: Open Payments
NPI 1528516705 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$70 in 4 payments from 4 companies in 2025. Trend: 2023 $34 · 2024 $45 · 2025 $70
Food & beverage: $70
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: VRAYLAR, FARXIGA, ZORYVE, Ozempic.
Industry payments across MO — which companies pay providers there.
